AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
MED BRIEFS.(HEALTH & MEDICINE)
Cardinal Health Buys U.K. Firm
The Dublin, Ohio, distributor of drugs and medical products said it will buy U.K.-based Intercare Group PLC for $530 million to expand its global reach. Intercare makes prefilled syringes. The deal awaits regulatory approval and is expected to close by year-end.
Eli Lilly Fixes Manufacturing Snags
The FDA had delayed Lilly's launch of depression drug Cymbalta and its approval of anti-psychotic Zyprexa IntraMuscular, pending the mends. The FDA site review will occur by year-end. Lilly had hoped to launch Cymbalta this year. Now, its delayed until mid-'04, cutting into earnings.
Drug-Coated Stent Has Risks
The FDA got 290 reports of clotting within 30 days after doctors implanted Johnson & Johnson's Cypher, the first drug-coated mesh cylinder that ...
- Corin Group PLC - Update on FDA Submission.
- News wire article from: Europe Intelligence Wire November 1, 2006 700+ words
...From AFX CNF) RNS Number:3600L Corin Group PLC 01 November 2006 1 November 2006 CORIN GROUP PLC Update on FDA Submission for Cormet Corin Group PLC (LSE: CRG, "Corin" or "the Group...
- Corin Group PLC - FDA Panel Update.
- News wire article from: Europe Intelligence Wire February 23, 2007 700+ words
...AFX CNF) RNS Number:7485R Corin Group PLC 22 February 2007 22 February 2007 CORIN GROUP PLC FDA Advisory Panel recommends approval...Cormet for US distribution Corin Group PLC (LSE: CRG, "Corin" or "the...
- Corin Group PLC - Update re FDA Panel Review.
- News wire article from: Europe Intelligence Wire January 4, 2007 700+ words
...CNF) RNS Number:9963O Corin Group PLC 04 January 2007 4 January 2007 CORIN GROUP PLC Update re FDA Panel Review and Pre Close Period Statement In November 2006, Corin Group PLC (LSE: CRG, "Corin" or "the...
- Shire Pharmaceuticals Group plc; FDA Response to Noven METHYPATCH(R)*.
- Press release article from: PR Newswire April 28, 2003 700+ words
Shire Pharmaceuticals Group plc notes today's announcement...letter from the U.S. FDA (Food & Drug Administration...Noven will meet with the FDA in the near future in...fully the nature of the FDA's concerns and discuss...Shire Pharmaceuticals Group plc Shire ...
- Phynova Group PLC - Phynova FDA Approval.
- News wire article from: Europe Intelligence Wire January 8, 2007 700+ words
...Number:1034P Phynova Group PLC 08 January 2007 For Immediate...8 January 2007 PHYNOVA GROUP PLC ("Phynova" or the "Group") Phynova obtains FDA approval of its IND to...chronic hepatitis C Phynova Group PLC (AIM: PYN), a developer...
- Corin Group PLC - FDA Advisory Panel for Cormet.
- News wire article from: Europe Intelligence Wire February 8, 2007 700+ words
(From AFX CNF) RNS Number:9266Q Corin Group PLC 08 February 2007 8 February 2007 CORIN GROUP PLC FDA Advisory Panel for Cormet Corin Group PLC (LSE: CRG, "Corin" or "the Group...
- 'Somnoplasty' From Gyrus Group PLC Receives FDA Clearance For Use in Teen and...
- Press release article from: PR Newswire June 18, 2002 700+ words
...READING, England -- Gyrus Group PLC, (GYG.L "Gyrus...To date the U.S. FDA has cleared Somnoplasty...opportunity for Gyrus Group PLC in the $1 billion head...editors About Gyrus Gyrus Group PLC is a growing medical technology...
- Shire Pharmaceuticals Group plc; FDA response to Noven Methypatch.
- News wire article from: Asia Africa Intelligence Wire April 28, 2003 700+ words
...Shire Pharmaceuticals Group plc (Shire) notes the announcement...Drug Administration (FDA) in response to its New...Noven will meet with the FDA in order to understand fully the nature of the FDA's concerns and discuss...Shire Pharmaceuticals Group plc is a rapidly growing ...
- Xenova Group plc, of Slough, UK, said the FDA granted fast-track status to its...
- Newspaper article from: BioWorld International October 9, 2002 700+ words
* Xenova Group plc, of Slough, UK, said the FDA granted fast-track status to its lead product, tariquidar, for the treatment of multidrug resistance in first-line treatment...
- CADx medical systems (Basingstoke, UK), a subsidiary of shire pharmaceuticals...
- Newspaper article from: The BBI Newsletter January 1, 2002 700+ words
...Basingstoke, UK), a subsidiary of Shire Pharmaceuticals Group plc, received an "approvable" letter from the FDA for its Second Look computer-aided detection system for...system is subject to final labeling discussions with the FDA.
